APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Contract Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharma Contract Service Market Outlook and Growth Opportunities 2026

1 January 2026190 pages

Choose your research edition.

Industry ResearchPharma Contract Service Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Contract Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pharma Contract Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Contract Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Contract Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pharma Contract Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharma Contract Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharma Contract Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Contract Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharma Contract Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharma Contract Service market include ICON PLC, IQVIA, PPD, Eurofins Scientific, WuXi AppTec, Labcorp Drug Development, Syneos Health, Parexel and Medpace, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharma Contract Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharma Contract Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma Contract Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharma Contract Service market.

Pharma Contract Service Segment by Company

ICON PLC

IQVIA

PPD

Eurofins Scientific

WuXi AppTec

Labcorp Drug Development

Syneos Health

Parexel

Medpace

Charles River

Lonza

Aldevron

Catalent

Pharma Contract Service Segment by Type

Contract Research Organization (CRO)

Contract Development and Manufacruring Organization (CDMO)

Contract Manufacturing Organization (CMO)

Pharma Contract Service Segment by Application

Pharmaceutical Company

Biotechnology Company

Generic Company

Pharma Contract Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharma Contract Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharma Contract Service key companies, revenue, market share, and recent developments.

3. To split the Pharma Contract Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharma Contract Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharma Contract Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharma Contract Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Contract Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Contract Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Contract Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Contract Service industry.

Chapter 3: Detailed analysis of Pharma Contract Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharma Contract Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharma Contract Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharma Contract Service Industry Trends Table 2. Pharma Contract Service Industry Drivers Table 3. Pharma Contract Service Industry Opportunities and Challenges Table 4. Pharma Contract Service Industry Restraints Table 5. Global Pharma Contract Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharma Contract Service Revenue Share by Company (2021-2026) Table 7. Global Pharma Contract Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharma Contract Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharma Contract Service Company, Product Type & Application Table 10. Global Pharma Contract Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharma Contract Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Contract Research Organization (CRO) Table 15. Significant Companies of Contract Development and Manufacruring Organization (CDMO) Table 16. Significant Companies of Contract Manufacturing Organization (CMO) Table 17. Global Pharma Contract Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pharma Contract Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pharma Contract Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pharma Contract Service Sales Value Share by Type (2021-2026) Table 21. Global Pharma Contract Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical Company Table 23. Significant Companies of Biotechnology Company Table 24. Significant Companies of Generic Company Table 25. Global Pharma Contract Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharma Contract Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pharma Contract Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pharma Contract Service Sales Value Share by Application (2021-2026) Table 29. Global Pharma Contract Service Sales Value Share by Application (2027-2032) Table 30. Global Pharma Contract Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharma Contract Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pharma Contract Service Sales Value Share by Region (2021-2026) Table 33. Global Pharma Contract Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pharma Contract Service Sales Value Share by Region (2027-2032) Table 35. Global Pharma Contract Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pharma Contract Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pharma Contract Service Sales Value Market Share by Country (2021-2026) Table 38. Global Pharma Contract Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pharma Contract Service Sales Value Market Share by Country (2027-2032) Table 40. ICON PLC Company Information Table 41. ICON PLC Business Overview Table 42. ICON PLC Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. ICON PLC Pharma Contract Service Product Portfolio Table 44. ICON PLC Recent Development Table 45. IQVIA Company Information Table 46. IQVIA Business Overview Table 47. IQVIA Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. IQVIA Pharma Contract Service Product Portfolio Table 49. IQVIA Recent Development Table 50. PPD Company Information Table 51. PPD Business Overview Table 52. PPD Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. PPD Pharma Contract Service Product Portfolio Table 54. PPD Recent Development Table 55. Eurofins Scientific Company Information Table 56. Eurofins Scientific Business Overview Table 57. Eurofins Scientific Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Eurofins Scientific Pharma Contract Service Product Portfolio Table 59. Eurofins Scientific Recent Development Table 60. WuXi AppTec Company Information Table 61. WuXi AppTec Business Overview Table 62. WuXi AppTec Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. WuXi AppTec Pharma Contract Service Product Portfolio Table 64. WuXi AppTec Recent Development Table 65. Labcorp Drug Development Company Information Table 66. Labcorp Drug Development Business Overview Table 67. Labcorp Drug Development Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Labcorp Drug Development Pharma Contract Service Product Portfolio Table 69. Labcorp Drug Development Recent Development Table 70. Syneos Health Company Information Table 71. Syneos Health Business Overview Table 72. Syneos Health Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Syneos Health Pharma Contract Service Product Portfolio Table 74. Syneos Health Recent Development Table 75. Parexel Company Information Table 76. Parexel Business Overview Table 77. Parexel Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Parexel Pharma Contract Service Product Portfolio Table 79. Parexel Recent Development Table 80. Medpace Company Information Table 81. Medpace Business Overview Table 82. Medpace Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Medpace Pharma Contract Service Product Portfolio Table 84. Medpace Recent Development Table 85. Charles River Company Information Table 86. Charles River Business Overview Table 87. Charles River Pharma Contract Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Charles River Pharma Contract Service Product Portfolio Table 89. Charles River Recent Development Table 90. Lonza Company Information Table 91. Lonza Business Overview Table 92. Lonza Pharma Contract Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Lonza Pharma Contract Service Product Portfolio Table 94. Lonza Recent Development Table 95. Aldevron Company Information Table 96. Aldevron Business Overview Table 97. Aldevron Pharma Contract Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Aldevron Pharma Contract Service Product Portfolio Table 99. Aldevron Recent Development Table 100. Catalent Company Information Table 101. Catalent Business Overview Table 102. Catalent Pharma Contract Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Catalent Pharma Contract Service Product Portfolio Table 104. Catalent Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Pharma Contract Service Product Image Figure 2. Global Pharma Contract Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharma Contract Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Contract Research Organization (CRO) Image Figure 8. Contract Development and Manufacruring Organization (CDMO) Image Figure 9. Contract Manufacturing Organization (CMO) Image Figure 10. Global Pharma Contract Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pharma Contract Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pharma Contract Service Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical Company Image Figure 14. Biotechnology Company Image Figure 15. Generic Company Image Figure 16. Global Pharma Contract Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharma Contract Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharma Contract Service Sales Value Share by Application (2021-2032) Figure 19. Global Pharma Contract Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pharma Contract Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pharma Contract Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pharma Contract Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pharma Contract Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pharma Contract Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pharma Contract Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pharma Contract Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pharma Contract Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pharma Contract Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pharma Contract Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pharma Contract Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pharma Contract Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pharma Contract Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pharma Contract Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organization (CRO)
  • Contract Development and Manufacruring Organization (CDMO)
  • Contract Manufacturing Organization (CMO)
Applications
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
Companies covered
  • ICON PLC
  • IQVIA
  • PPD
  • Eurofins Scientific
  • WuXi AppTec
  • Labcorp Drug Development
  • Syneos Health
  • Parexel
  • Medpace
  • Charles River
  • Lonza
  • Aldevron
  • Catalent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharma Contract Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharma Contract Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharma Contract Service Market Dynamics
  1. 2.1 Pharma Contract Service Industry Trends
  2. 2.2 Pharma Contract Service Industry Drivers
  3. 2.3 Pharma Contract Service Industry Opportunities and Challenges
  4. 2.4 Pharma Contract Service Industry Restraints
3 Pharma Contract Service Market by Company
  1. 3.1 Global Pharma Contract Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharma Contract Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharma Contract Service Company Ranking (2024-2026)
  4. 3.4 Global Pharma Contract Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharma Contract Service Company Product Type and Application
  6. 3.6 Global Pharma Contract Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharma Contract Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharma Contract Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharma Contract Service Market by Type
  1. 4.1 Pharma Contract Service Type Introduction
  2. 4.1.1 Contract Research Organization (CRO)
  3. 4.1.2 Contract Development and Manufacruring Organization (CDMO)
  4. 4.1.3 Contract Manufacturing Organization (CMO)
  5. 4.2 Global Pharma Contract Service Sales Value by Type
  6. 4.2.1 Global Pharma Contract Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pharma Contract Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pharma Contract Service Sales Value Share by Type (2021-2032)
5 Pharma Contract Service Market by Application
  1. 5.1 Pharma Contract Service Application Introduction
  2. 5.1.1 Pharmaceutical Company
  3. 5.1.2 Biotechnology Company
  4. 5.1.3 Generic Company
  5. 5.2 Global Pharma Contract Service Sales Value by Application
  6. 5.2.1 Global Pharma Contract Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharma Contract Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharma Contract Service Sales Value Share by Application (2021-2032)
6 Pharma Contract Service Regional Value Analysis
  1. 6.1 Global Pharma Contract Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharma Contract Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharma Contract Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharma Contract Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharma Contract Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharma Contract Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharma Contract Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharma Contract Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharma Contract Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharma Contract Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharma Contract Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharma Contract Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharma Contract Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharma Contract Service Sales Value Share by Country, 2025 VS 2032
7 Pharma Contract Service Country-level Value Analysis
  1. 7.1 Global Pharma Contract Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharma Contract Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharma Contract Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharma Contract Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharma Contract Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharma Contract Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharma Contract Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharma Contract Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharma Contract Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharma Contract Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharma Contract Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharma Contract Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharma Contract Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharma Contract Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharma Contract Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharma Contract Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharma Contract Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharma Contract Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharma Contract Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharma Contract Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharma Contract Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharma Contract Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharma Contract Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharma Contract Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharma Contract Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharma Contract Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharma Contract Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharma Contract Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharma Contract Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharma Contract Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharma Contract Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharma Contract Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharma Contract Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharma Contract Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ICON PLC
  2. 8.1.1 ICON PLC Company Information
  3. 8.1.2 ICON PLC Business Overview
  4. 8.1.3 ICON PLC Pharma Contract Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ICON PLC Pharma Contract Service Product Portfolio
  6. 8.1.5 ICON PLC Recent Developments
  7. 8.2 IQVIA
  8. 8.2.1 IQVIA Company Information
  9. 8.2.2 IQVIA Business Overview
  10. 8.2.3 IQVIA Pharma Contract Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IQVIA Pharma Contract Service Product Portfolio
  12. 8.2.5 IQVIA Recent Developments
  13. 8.3 PPD
  14. 8.3.1 PPD Company Information
  15. 8.3.2 PPD Business Overview
  16. 8.3.3 PPD Pharma Contract Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PPD Pharma Contract Service Product Portfolio
  18. 8.3.5 PPD Recent Developments
  19. 8.4 Eurofins Scientific
  20. 8.4.1 Eurofins Scientific Company Information
  21. 8.4.2 Eurofins Scientific Business Overview
  22. 8.4.3 Eurofins Scientific Pharma Contract Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eurofins Scientific Pharma Contract Service Product Portfolio
  24. 8.4.5 Eurofins Scientific Recent Developments
  25. 8.5 WuXi AppTec
  26. 8.5.1 WuXi AppTec Company Information
  27. 8.5.2 WuXi AppTec Business Overview
  28. 8.5.3 WuXi AppTec Pharma Contract Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi AppTec Pharma Contract Service Product Portfolio
  30. 8.5.5 WuXi AppTec Recent Developments
  31. 8.6 Labcorp Drug Development
  32. 8.6.1 Labcorp Drug Development Company Information
  33. 8.6.2 Labcorp Drug Development Business Overview
  34. 8.6.3 Labcorp Drug Development Pharma Contract Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labcorp Drug Development Pharma Contract Service Product Portfolio
  36. 8.6.5 Labcorp Drug Development Recent Developments
  37. 8.7 Syneos Health
  38. 8.7.1 Syneos Health Company Information
  39. 8.7.2 Syneos Health Business Overview
  40. 8.7.3 Syneos Health Pharma Contract Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Syneos Health Pharma Contract Service Product Portfolio
  42. 8.7.5 Syneos Health Recent Developments
  43. 8.8 Parexel
  44. 8.8.1 Parexel Company Information
  45. 8.8.2 Parexel Business Overview
  46. 8.8.3 Parexel Pharma Contract Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Parexel Pharma Contract Service Product Portfolio
  48. 8.8.5 Parexel Recent Developments
  49. 8.9 Medpace
  50. 8.9.1 Medpace Company Information
  51. 8.9.2 Medpace Business Overview
  52. 8.9.3 Medpace Pharma Contract Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medpace Pharma Contract Service Product Portfolio
  54. 8.9.5 Medpace Recent Developments
  55. 8.10 Charles River
  56. 8.10.1 Charles River Company Information
  57. 8.10.2 Charles River Business Overview
  58. 8.10.3 Charles River Pharma Contract Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Charles River Pharma Contract Service Product Portfolio
  60. 8.10.5 Charles River Recent Developments
  61. 8.11 Lonza
  62. 8.11.1 Lonza Company Information
  63. 8.11.2 Lonza Business Overview
  64. 8.11.3 Lonza Pharma Contract Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lonza Pharma Contract Service Product Portfolio
  66. 8.11.5 Lonza Recent Developments
  67. 8.12 Aldevron
  68. 8.12.1 Aldevron Company Information
  69. 8.12.2 Aldevron Business Overview
  70. 8.12.3 Aldevron Pharma Contract Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aldevron Pharma Contract Service Product Portfolio
  72. 8.12.5 Aldevron Recent Developments
  73. 8.13 Catalent
  74. 8.13.1 Catalent Company Information
  75. 8.13.2 Catalent Business Overview
  76. 8.13.3 Catalent Pharma Contract Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Catalent Pharma Contract Service Product Portfolio
  78. 8.13.5 Catalent Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst